EFPIA：2025年改善欧盟临床试验：克服当前挑战和加强生态系统的建议报告（英文版）

Clinical trials are one of the most critical, expensive and time-consuming stages of the drug development process. An effective and harmonised regulatory framework is essential—not only to maintain the EU’s global competitiveness in pharmaceutical innovation, but also to ensure patients with unmet medical needs can access the latest scientific breakthroughs.